Page last updated: 2024-11-07

dehydroepiandrosterone and Urinary Incontinence, Urge

dehydroepiandrosterone has been researched along with Urinary Incontinence, Urge in 2 studies

Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.

Urinary Incontinence, Urge: Involuntary discharge of URINE that is associated with an abrupt and strong desire to void. It is usually related to the involuntary contractions of the detrusor muscle of the bladder (detrusor hyperreflexia or detrusor instability).

Research Excerpts

ExcerptRelevanceReference
"The aim of this study was to compare the efficacy of the transobturator tape (TOT) procedure combined with solifenacin (TOT-S) or prasterone (TOT-P) in postmenopausal women affected by mixed urinary incontinence (MUI) with a predominant stress urinary incontinence component."1.91TOT in combination with solifenacin or intravaginal prasterone in postmenopausal women with mixed urinary incontinence: A retrospective analysis in 112 patients. ( Cardella, G; Grossi, G; Loggia, M; Morgani, C; Palazzetti, PL; Sala, F; Schiavi, MC; Valensise, HCC; Zullo, MA, 2023)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
CollĂ  Ruvolo, C1
Gabrielli, O1
Formisano, C1
Califano, G1
Manna, P1
Venturella, R1
Di Carlo, C1
Sala, F1
Loggia, M1
Cardella, G1
Morgani, C1
Grossi, G1
Zullo, MA1
Valensise, HCC1
Palazzetti, PL1
Schiavi, MC1

Other Studies

2 other studies available for dehydroepiandrosterone and Urinary Incontinence, Urge

ArticleYear
Prasterone in the treatment of mild to moderate urge incontinence: an observational study.
    Menopause (New York, N.Y.), 2022, 08-01, Volume: 29, Issue:8

    Topics: Dehydroepiandrosterone; Female; Humans; Hyaluronic Acid; Male; Prospective Studies; Quality of Life;

2022
TOT in combination with solifenacin or intravaginal prasterone in postmenopausal women with mixed urinary incontinence: A retrospective analysis in 112 patients.
    Lower urinary tract symptoms, 2023, Volume: 15, Issue:3

    Topics: Dehydroepiandrosterone; Female; Humans; Postmenopause; Quality of Life; Retrospective Studies; Solif

2023